Transcranial Temporal Interference Stimulation In Severely Brain Injured Patients With Disorders of Consciousness
Not Applicable
Recruiting
- Conditions
- Disorders of ConsciousnessSevere Brain InjuryUnresponsive Wakefulness SyndromeMinimally Conscious State
- Registration Number
- NCT06851156
- Lead Sponsor
- Xijing Hospital
- Brief Summary
The purpose of this academic lead study is to explore the effect of noninvasive neuromodulation of the CM-pf via tTIS for patients with disorders of consciousness.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
- traumatic and nontraumatic etiology of VS/UWS or MCS according to published diagnostic criteria.
Exclusion Criteria
- patients in coma, with less than 1 week after acute brain insult, with fluctuating diagnosis on baseline assessment, and with a metallic cerebral implant or pacemaker, and with epilepsy.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method CRS-R total score changes From enrollment to the end of treatment at 10 days Coma Recovery Scale-Revised scale score, with score ranging from 0 to 23, was used to evaluate the consciousness condition.
- Secondary Outcome Measures
Name Time Method Numbers of patients with improved consciousness From enrollment to the end of treatment at 10 days EEG changes From enrollment to the end of treatment at 10 days EEG power spectra, Connectivity and ABCD model, etc
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What neural pathways and neurotransmitter systems are modulated by tTIS targeting the CM-pf in disorders of consciousness?
How does transcranial temporal interference stimulation compare to pharmacological agents like amantadine in improving consciousness in severe brain injury patients?
Which neuroimaging or electrophysiological biomarkers predict response to CM-pf tTIS in disorders of consciousness?
What are the potential adverse events of transcranial temporal interference stimulation in brain-injured patients and their management strategies?
Are there combination therapies involving tTIS and pharmacological agents for enhancing neural plasticity in disorders of consciousness?
Trial Locations
- Locations (1)
Xijing Hospital
🇨🇳Xi'an, Shaanxi, China
Xijing Hospital🇨🇳Xi'an, Shaanxi, ChinaGengyao HuContact86-029-84771794customer@notice.rh-clinical.comchairman of committeeContact86-029-84771794customer@notice.rh-clinical.com